Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' DEFICIT (Details Narrative)

v2.4.0.8
STOCKHOLDERS' DEFICIT (Details Narrative) (USD $)
 3 Months Ended
Mar. 31, 2014
Preferred stock, shares authorized 20,000,000
Common stock, shares authorized 200,000,000
Common stock, shares issued 1,510,950
Common stock, shares outstanding 1,510,950
Stock options, value $ 405,000
Warrants outstanding at end of period 245,000
Uribe
  
Non-employee director monthly fees 1,000
Non-employee option issued 30,000
Exercise price, per share, for common stock $ 0.0001
Valued common shares at the fair market value, per share $ 3.00
Valued common shares at the fair market value 179,834
Volatility rate 260.00%
Expected term 4 years
Risk-free interest rate 0.81%
Stock based consulting expense 179,834
Bhansali
  
Non-employee director monthly fees $ 1,000
Non-employee option issued 30,000
Exercise price, per share, for common stock $ 0.0001
Volatility rate 260.00%
Expected term 4 years
Risk-free interest rate 0.81%
2014 Plan
  
Share based compensation, shares issuable 226,667
Share based compensation, vesting terms issuance no later than sixty (60) days following the date of shareholder approval of the Plan in connection with (i) a private placement of the Company’s securities in which the Corporation receives gross proceeds of at least $1,000,000 and (ii) an acquisition of at least 50 mining leases and/or claims in the Holbrook Basin.
Preferred stock, Series B
  
Preferred stock, shares authorized 30,000
Preferred stock, shares outstanding 6,666
Preferred Stock Series A
  
Preferred stock, shares authorized 20,000
Preferred stock, shares outstanding 20,000